Research

Research

UConn School of Medicine is home to many cutting-edge research programs with renowned research teams propelling powerful discoveries and innovations. Since the medical school’s inception, part of its institutional fabric has been its commitment to advancing scientific and medical discovery by growing high-quality research programs. Today, our research enterprise has reached new heights with year-after-year landmark funding exceeding $100 million. Our research expertise knows no boundaries spanning across disciplines, campuses, state and international lines, from basic science to clinical research and trials, to translational research at the patient’s bedside, to population, public, behavioral and social health arenas. Our goal is improving the health and well-being of the people of Connecticut and the globe by translating our discoveries into new patient care advances, health care technologies, and biotech start-up companies.

UConn Science in seconds

Science in Seconds

Got a minute? Take a look at our latest research happening.

Science in Seconds


Fruit fly germ cells are visualized by germline-specific expression of Tubulin-GFP (magenta), and DNA is marked by counterstaining with DAPI (cyan). The yellow dots show expression of Stat92E, which gradually declines as the stem cells transform into sperm (Contributed image).

Lab Notes

Read our research blog for the latest study publications.

Lab Notes

Research

Faculty in the School of Medicine are actively involved in a variety of innovative and cutting edge basic science, epidemiological, biobehavioral, and clinical/translational research activities. A major focus of this effort is the translation of our discoveries into advances in patient care and the licensing of new technologies and devices to the private sector.

In the News

Welcome Recent Research Hires

Dr. Margaret Callahan joins UConn as the Chief of the Division of Hematology Oncology at the Carole and Ray Neag Comprehensive Cancer Center. She is a medical oncologist, with expertise in Melanoma and Phase 1 Clinical Trials. She is an NIH funded researcher focused on developing biomarkers to guide the use of immunotherapy for cancer treatment. 

Dr. Danielle Rux's research centers on studying the fundamental mechanisms that drive synovial joint development and articular cartilage morphogenesis. Her research program will enhance knowledge of cartilage degeneration that results from joint disease/injury such as osteoarthritis and will also inform new preventative treatments and regenerative therapies.


In the News


Got Research News?

Do you have an embargoed research publication or national meeting abstract presentation coming up? If you think it might catch the media’s attention due to its significant impact on the future of health sciences or patient care, please fill out this online form before the embargo lifts to have it featured by UConn Health’s News Team.